Higher doses of CD34+ progenitors are associated with improved overall survival without increasing GVHD in reduced intensity conditioning allogeneic transplant recipients with clinically advanced disease.

Gómez-Almaguer D, Gómez-Peña A, Jaime-Pérez JCarlos, Gómez-Guijosa MÁngel, Cantú-Rodríguez O, Gutiérrez-Aguirre H, Martínez-Cabriales SAidé, García-Rodríguez F, Olguín-Ramírez LA, Salazar-Riojas R, et al. Higher doses of CD34+ progenitors are associated with improved overall survival without increasing GVHD in reduced intensity conditioning allogeneic transplant recipients with clinically advanced disease. J Clin Apher. 2013.